Variety and complexity of chromosome 17 translocations in neuroblastoma
- 26 November 2003
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 39 (2) , 143-150
- https://doi.org/10.1002/gcc.10313
Abstract
In neuroblastoma, the most frequent genetic alteration is gain of chromosome arm 17q, which arises from unbalanced translocations. To document these genetic events more precisely, we performed an extensive study of chromosome 17 breakpoints in 27 neuroblastoma cell lines by using a combination of fluorescence in situ hybridization mapping with BAC/PAC clones and allele analysis with polymorphic markers. All cases exhibited one or more unbalanced chromosome 17 translocations, and 15 distinct breakpoint regions could be mapped. This high variability indicates that gene fusion or disruption events are extremely unlikely to account for the underlying oncogenic role of these translocations. However, breakpoints were not randomly distributed, most of them mapping to the proximal part of 17q. As a result of translocations, all cell lines but one exhibited gain of the 53.5 Mb→qter fragment, bordered proximally by the clone CTC‐462L7. The most telomeric breakpoint, flanked by the clone RP11‐443M10, defined the 70.9 Mb→qter fragment as a region of additional gain. In addition to chromosome gains, loss of heterozygosity for the short arm of chromosome 17 was observed in close to half the cases. It was either related to a chromosome 17 monosomy or to a uniparental isodisomy. Finally, in cases with a single normal chromosome 17, we show that the parental origin of the translocated chromosome 17 can be either distinct or identical to that of the normal chromosome. Similarly, multiple translocations within the same cell line can either involve the same or different chromosome 17 homologues, indicating the likely absence of parental origin bias in the generation of these alterations.Keywords
This publication has 20 references indexed in Scilit:
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003
- The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2Oncogene, 2002
- Neuroblastoma tumour genetics: clinical and biological aspectsJournal of Clinical Pathology, 2001
- Comprehensive Genetic and Histopathologic Study Reveals Three Types of Neuroblastoma TumorsJournal of Clinical Oncology, 2001
- Molecular analysis of chromosome arm 17q gain in neuroblastomaGenes, Chromosomes and Cancer, 2000
- High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastomaOncogene, 2000
- Gain of Chromosome Arm 17q and Adverse Outcome in Patients with NeuroblastomaNew England Journal of Medicine, 1999
- Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell linesGenes, Chromosomes and Cancer, 1998
- Promiscuous translocations of chromosome arm 17q in human neuroblastomasGenes, Chromosomes and Cancer, 1997
- COMPARATIVE GENOMIC HYBRIDIZATION (CGH) ANALYSIS OF NEUROBLASTOMAS—AN IMPORTANT METHODOLOGICAL APPROACH IN PAEDIATRIC TUMOUR PATHOLOGYThe Journal of Pathology, 1997